AZD4320
AZD4320 Basic information
- Product Name:
- AZD4320
- Synonyms:
-
- AZD4320
- Benzamide, 4-[4-[(R)-(4'-chloro[1,1'-biphenyl]-2-yl)hydroxymethyl]-1-piperidinyl]-N-[[4-[[(1R)-3-[(2-hydroxyethyl)methylamino]-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]-
- Bcl-2 Family,Inhibitor,inhibit,AZD4320,AZD 4320,AZD-4320
- 4-(4-((R)-(4'-Chloro-[1,1'-biphenyl]-2-yl)(hydroxy)methyl)piperidin-1-yl)-N-((4-(((R)-4-((2-hydroxyethyl)(methyl)amino)-1-(phenylthio)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)benzamide
- AZD4320, 10 mM in DMSO
- CAS:
- 1357576-48-7
- MF:
- C45H48ClF3N4O7S3
- MW:
- 945.53
- Mol File:
- 1357576-48-7.mol
More
Less
AZD4320 Chemical Properties
- Density
- 1.46±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO: 125 mg/mL (132.20 mM)
- form
- Solid
- pka
- 4.70±0.10(Predicted)
- color
- White to off-white
More
Less
AZD4320 Usage And Synthesis
Uses
AZD4320 is a novel BH3-mimicking dual BCL2/BCLxL inhibitor with IC50s of 26 nM, 17 nM, and 170 nM for KPUM-MS3, KPUM-UH1, and STR-428 cells, respectively.
IC 50
BCL2: 17 nM (IC50, KPUM-UH1 cells); BCLxL: 17 nM (IC50, KPUM-UH1 cells)
References
[1] Takimoto-Shimomura T, et al. Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2. Invest New Drugs. 2018 Jun 21. DOI:10.1007/s10637-018-0623-8
AZD4320Supplier
BOC Sciences
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
ShangHai Caerulum Pharma Discovery Co., Ltd.
- Tel
- 18149758185
- sales-cpd@caerulumpharma.com
Shanghai Lollane Biological Technology Co.,Ltd.
- Tel
- 021-52996696，15000506266 15000506266
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com
Amadis Chemical Company Limited
- Tel
- 571-89925085
- sales@amadischem.com